nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—periodontitis	0.852	1	CbGaD
Danazol—ESR1—periosteum—periodontitis	0.00668	0.14	CbGeAlD
Danazol—CCL2—endothelium—periodontitis	0.00599	0.125	CbGeAlD
Danazol—CCL2—mouth—periodontitis	0.00462	0.0967	CbGeAlD
Danazol—CCL2—neck—periodontitis	0.00395	0.0827	CbGeAlD
Danazol—CCL2—trigeminal ganglion—periodontitis	0.00341	0.0714	CbGeAlD
Danazol—CCL2—parotid gland—periodontitis	0.00322	0.0673	CbGeAlD
Danazol—CCL2—connective tissue—periodontitis	0.00283	0.0593	CbGeAlD
Danazol—CCL2—epithelium—periodontitis	0.00269	0.0563	CbGeAlD
Danazol—SHBG—neck—periodontitis	0.0023	0.0482	CbGeAlD
Danazol—SHBG—connective tissue—periodontitis	0.00165	0.0346	CbGeAlD
Danazol—ESR1—neck—periodontitis	0.00162	0.034	CbGeAlD
Danazol—PGR—connective tissue—periodontitis	0.00149	0.0311	CbGeAlD
Danazol—PGR—epithelium—periodontitis	0.00141	0.0296	CbGeAlD
Danazol—CYP19A1—connective tissue—periodontitis	0.00134	0.028	CbGeAlD
Danazol—AR—connective tissue—periodontitis	0.00119	0.0248	CbGeAlD
Danazol—ESR1—connective tissue—periodontitis	0.00116	0.0244	CbGeAlD
Danazol—AR—epithelium—periodontitis	0.00113	0.0236	CbGeAlD
Danazol—ESR1—epithelium—periodontitis	0.0011	0.0231	CbGeAlD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00066	0.00657	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—periodontitis	0.000643	0.0064	CbGpPWpGaD
Danazol—PGR—Nuclear Receptors—PPARA—periodontitis	0.000637	0.00634	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCR2—periodontitis	0.000634	0.00631	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000604	0.00601	CbGpPWpGaD
Danazol—PGR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.000597	0.00594	CbGpPWpGaD
Danazol—PGR—Cellular roles of Anthrax toxin—IL1B—periodontitis	0.000597	0.00594	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IFNG—periodontitis	0.000592	0.00589	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—MMP9—periodontitis	0.000581	0.00578	CbGpPWpGaD
Danazol—AR—Nuclear Receptors—VDR—periodontitis	0.000575	0.00572	CbGpPWpGaD
Danazol—CYP19A1—Ovarian Infertility Genes—VDR—periodontitis	0.000568	0.00565	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—CRP—periodontitis	0.000547	0.00544	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL1B—periodontitis	0.000528	0.00525	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL1A—periodontitis	0.000517	0.00515	CbGpPWpGaD
Danazol—CCL2—Chemokine receptors bind chemokines—CXCL8—periodontitis	0.000511	0.00508	CbGpPWpGaD
Danazol—PGR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000503	0.00501	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCL3—periodontitis	0.000503	0.005	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL4—periodontitis	0.0005	0.00498	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—IL1B—periodontitis	0.000497	0.00494	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—TNF—periodontitis	0.000495	0.00493	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CCR2—periodontitis	0.000493	0.00491	CbGpPWpGaD
Danazol—AR—Nuclear Receptors—PPARA—periodontitis	0.000485	0.00483	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IFNG—periodontitis	0.000482	0.00479	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL3—periodontitis	0.00046	0.00457	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IFNG—periodontitis	0.000459	0.00457	CbGpPWpGaD
Danazol—AR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.000455	0.00452	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—TNF—periodontitis	0.000447	0.00445	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—VDR—periodontitis	0.000443	0.00441	CbGpPWpGaD
Danazol—PGR—Cellular roles of Anthrax toxin—TNF—periodontitis	0.000433	0.00431	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL1B—periodontitis	0.000429	0.00427	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CXCL8—periodontitis	0.000427	0.00425	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000425	0.00423	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TLR4—periodontitis	0.000415	0.00413	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—periodontitis	0.0004	0.00398	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL6—periodontitis	0.0004	0.00398	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—NOS2—periodontitis	0.000394	0.00392	CbGpPWpGaD
Danazol—CCL2—Unfolded Protein Response (UPR)—CXCL8—periodontitis	0.000392	0.0039	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000389	0.00387	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—MMP9—periodontitis	0.000386	0.00384	CbGpPWpGaD
Danazol—AR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000383	0.00382	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—periodontitis	0.000383	0.00381	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IFNG—periodontitis	0.000383	0.00381	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—PPARA—periodontitis	0.000374	0.00372	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—PTGS2—periodontitis	0.000367	0.00365	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TIMP1—periodontitis	0.000362	0.0036	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—IL6—periodontitis	0.000361	0.00359	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000353	0.00351	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—VDR—periodontitis	0.00035	0.00348	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—IL1RN—periodontitis	0.00035	0.00348	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL1B—periodontitis	0.000341	0.00339	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000331	0.00329	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000329	0.00328	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCR2—periodontitis	0.000324	0.00322	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TGFB1—periodontitis	0.000318	0.00317	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—VDR—periodontitis	0.000314	0.00312	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TNF—periodontitis	0.000312	0.0031	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00031	0.00308	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL6—periodontitis	0.000309	0.00308	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—periodontitis	0.000305	0.00304	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000303	0.00301	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IFNG—periodontitis	0.000303	0.00301	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000301	0.003	CbGpPWpGaD
Danazol—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.000296	0.00295	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCR2—periodontitis	0.000296	0.00295	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000295	0.00294	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—PTGS2—periodontitis	0.00029	0.00289	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL13—periodontitis	0.000289	0.00288	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—CXCL8—periodontitis	0.000281	0.0028	CbGpPWpGaD
Danazol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.000275	0.00274	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL1B—periodontitis	0.00027	0.00268	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—periodontitis	0.000267	0.00266	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL10—periodontitis	0.000264	0.00263	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—MMP2—periodontitis	0.000262	0.00261	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL3—periodontitis	0.00026	0.00259	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—periodontitis	0.00026	0.00258	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL3—periodontitis	0.000258	0.00257	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL4—periodontitis	0.000257	0.00256	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—MMP9—periodontitis	0.000254	0.00253	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.000253	0.00251	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCR2—periodontitis	0.000252	0.00251	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL6—periodontitis	0.000251	0.0025	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—ADRB1—periodontitis	0.000251	0.0025	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—TNF—periodontitis	0.000248	0.00246	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—periodontitis	0.000242	0.00241	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL6—periodontitis	0.00024	0.00239	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—periodontitis	0.000239	0.00238	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL3—periodontitis	0.000236	0.00235	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—periodontitis	0.000235	0.00234	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—NOS2—periodontitis	0.000232	0.00231	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCR2—periodontitis	0.00023	0.00229	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—ADRB1—periodontitis	0.000229	0.00228	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP1—periodontitis	0.000225	0.00224	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TGFB1—periodontitis	0.00021	0.00209	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.000209	0.00208	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—periodontitis	0.000203	0.00202	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—periodontitis	0.000201	0.002	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL6—periodontitis	0.0002	0.00199	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—MMP2—periodontitis	0.000199	0.00198	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—periodontitis	0.000196	0.00195	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—periodontitis	0.000193	0.00192	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL8—periodontitis	0.000192	0.00191	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—VIP—periodontitis	0.000188	0.00187	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—VIP—periodontitis	0.000187	0.00186	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CCL2—periodontitis	0.000183	0.00182	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1A—periodontitis	0.000182	0.00181	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—periodontitis	0.000181	0.0018	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IFNG—periodontitis	0.000178	0.00177	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000176	0.00175	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GGT1—periodontitis	0.000174	0.00173	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—VIP—periodontitis	0.000171	0.0017	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—periodontitis	0.000169	0.00168	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCR2—periodontitis	0.000167	0.00167	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCR2—periodontitis	0.000166	0.00165	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—CXCL8—periodontitis	0.000166	0.00165	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IFNG—periodontitis	0.000159	0.00158	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL6—periodontitis	0.000158	0.00157	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000158	0.00157	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.000158	0.00157	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IFNG—periodontitis	0.000155	0.00155	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—periodontitis	0.000153	0.00152	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL3—periodontitis	0.000152	0.00152	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCR2—periodontitis	0.000152	0.00151	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—FGF2—periodontitis	0.000151	0.00151	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.000149	0.00148	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CXCL8—periodontitis	0.000145	0.00144	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000141	0.0014	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL3—periodontitis	0.000139	0.00139	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.000136	0.00135	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000136	0.00135	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000133	0.00133	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—IL1B—periodontitis	0.000131	0.00131	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP9—periodontitis	0.000131	0.0013	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CCR2—periodontitis	0.00013	0.0013	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—ADRB1—periodontitis	0.00013	0.00129	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCR2—periodontitis	0.000129	0.00129	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000129	0.00128	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—ADRB1—periodontitis	0.000129	0.00128	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.000122	0.00121	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCR2—periodontitis	0.000118	0.00118	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000118	0.00117	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—ADRB1—periodontitis	0.000118	0.00117	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL2—periodontitis	0.000114	0.00113	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—periodontitis	0.00011	0.0011	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VIP—periodontitis	0.00011	0.0011	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—periodontitis	0.000108	0.00107	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP1—periodontitis	0.000107	0.00107	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—VDR—periodontitis	0.000103	0.00103	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VIP—periodontitis	0.000101	0.001	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CXCL8—periodontitis	9.89e-05	0.000984	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCR2—periodontitis	9.82e-05	0.000977	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCL8—periodontitis	9.81e-05	0.000977	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MMP3—periodontitis	9.8e-05	0.000975	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	9.61e-05	0.000956	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—periodontitis	9.48e-05	0.000944	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—periodontitis	9.31e-05	0.000927	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC52A3—periodontitis	9.09e-05	0.000905	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCR2—periodontitis	8.98e-05	0.000894	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL8—periodontitis	8.98e-05	0.000893	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MMP3—periodontitis	8.96e-05	0.000892	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	8.94e-05	0.00089	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FGF2—periodontitis	8.89e-05	0.000884	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL3—periodontitis	8.79e-05	0.000875	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—PPARA—periodontitis	8.69e-05	0.000865	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	8.67e-05	0.000863	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP2—periodontitis	8.31e-05	0.000827	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—periodontitis	8.12e-05	0.000808	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—VDR—periodontitis	7.85e-05	0.000781	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR2—periodontitis	7.64e-05	0.00076	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADRB1—periodontitis	7.6e-05	0.000757	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—periodontitis	7.44e-05	0.00074	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	7.4e-05	0.000737	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR2—periodontitis	6.99e-05	0.000695	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADRB1—periodontitis	6.95e-05	0.000692	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CXCL8—periodontitis	6.9e-05	0.000687	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—periodontitis	6.88e-05	0.000685	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	6.69e-05	0.000666	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	6.68e-05	0.000665	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARA—periodontitis	6.62e-05	0.000659	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VIP—periodontitis	6.35e-05	0.000632	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	6.27e-05	0.000624	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NTRK1—periodontitis	6.23e-05	0.000619	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—VDR—periodontitis	6.05e-05	0.000602	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.85e-05	0.000582	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL2—periodontitis	5.83e-05	0.00058	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP3—periodontitis	5.79e-05	0.000576	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NTRK1—periodontitis	5.69e-05	0.000567	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCR2—periodontitis	5.66e-05	0.000564	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—periodontitis	5.55e-05	0.000553	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ACP5—periodontitis	5.36e-05	0.000533	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP3—periodontitis	5.29e-05	0.000527	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL3—periodontitis	5.16e-05	0.000513	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARA—periodontitis	5.1e-05	0.000508	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GGT1—periodontitis	5.09e-05	0.000506	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL8—periodontitis	5.07e-05	0.000505	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL8—periodontitis	5.04e-05	0.000501	CbGpPWpGaD
Danazol—PGR—Gene Expression—VDR—periodontitis	4.96e-05	0.000494	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	4.83e-05	0.00048	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.79e-05	0.000477	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL8—periodontitis	4.61e-05	0.000458	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	4.51e-05	0.000449	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR2—periodontitis	4.4e-05	0.000438	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB1—periodontitis	4.39e-05	0.000436	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—periodontitis	4.37e-05	0.000435	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARA—periodontitis	4.19e-05	0.000416	CbGpPWpGaD
Danazol—AR—Gene Expression—VDR—periodontitis	3.78e-05	0.000376	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VIP—periodontitis	3.73e-05	0.000371	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK1—periodontitis	3.59e-05	0.000357	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—periodontitis	3.44e-05	0.000342	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGF2—periodontitis	3.4e-05	0.000338	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP3—periodontitis	3.34e-05	0.000332	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR2—periodontitis	3.32e-05	0.000331	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARA—periodontitis	3.19e-05	0.000317	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	3.12e-05	0.00031	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGF2—periodontitis	3.11e-05	0.00031	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GGT1—periodontitis	2.98e-05	0.000297	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—periodontitis	2.98e-05	0.000296	CbGpPWpGaD
Danazol—ESR1—Gene Expression—VDR—periodontitis	2.91e-05	0.00029	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—periodontitis	2.83e-05	0.000282	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—periodontitis	2.72e-05	0.000271	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—periodontitis	2.69e-05	0.000268	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC52A3—periodontitis	2.65e-05	0.000264	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—periodontitis	2.59e-05	0.000257	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR2—periodontitis	2.59e-05	0.000257	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB1—periodontitis	2.57e-05	0.000256	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—periodontitis	2.46e-05	0.000245	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—periodontitis	2.46e-05	0.000244	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—periodontitis	2.22e-05	0.000221	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—periodontitis	2.17e-05	0.000216	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—periodontitis	2.13e-05	0.000212	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK1—periodontitis	2.11e-05	0.00021	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—periodontitis	2.03e-05	0.000202	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF2—periodontitis	1.96e-05	0.000195	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP3—periodontitis	1.96e-05	0.000195	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—periodontitis	1.72e-05	0.000171	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—periodontitis	1.67e-05	0.000166	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACP5—periodontitis	1.56e-05	0.000156	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—periodontitis	1.55e-05	0.000154	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—periodontitis	1.53e-05	0.000152	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—periodontitis	1.39e-05	0.000138	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—periodontitis	1.28e-05	0.000127	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—periodontitis	1.27e-05	0.000127	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF2—periodontitis	1.15e-05	0.000115	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—periodontitis	1.01e-05	0.0001	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—periodontitis	9.64e-06	9.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—periodontitis	9.11e-06	9.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT1—periodontitis	8.7e-06	8.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—periodontitis	7.51e-06	7.47e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—periodontitis	6.23e-06	6.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—periodontitis	5.66e-06	5.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—periodontitis	4.05e-06	4.03e-05	CbGpPWpGaD
